Results 231 to 240 of about 213,913 (289)

Stochastic Simulation Model for Forecasting Index‐Linked Public Expenditure

Public Budgeting &Finance, EarlyView.
Abstract This paper introduces a system dynamics (SD) model for analyzing public sector cost growth, where costs are tied to indices. The SD model isolates the effects of automatic indexation, providing probabilistic projections of expenditure growth. It enables testing of alternative indexation strategies and cost‐reduction measures. Findings show how
Miia Rissanen, Jyrki Savolainen, Mikael Collan   +2 more
wiley   +1 more source

Advancing the Study of Glioblastoma Through 3D Tumor Models. [PDF]

Cancers (Basel)
Salmeron-Moreno K, Buclez J, Kim CD, Papisetty K, McCaffery T, Jacob F, Kashlan R, Duggireddy H, Valiveti K, Maldonado J, Pradilla G, Garzon-Muvdi T.   +11 more
europepmc   +1 more source

Conditional survival in glioblastoma: The evolution of prognostic factors over time

International Journal of Cancer, Volume 158, Issue 10, Page 2571-2580, 15 May 2026.
What's New? Neurooncologists rely on glioblastoma risk stratification systems for incorporating known disease‐ and patient‐specific factors at diagnosis. Although useful for general comparison and disease monitoring, these estimates are less informative for patients who survive beyond various time intervals post‐diagnosis.
Timothy Mueller, Flavio Vasella, Julia Velz, Stefanos Voglis, Kevin Akeret, Luis Padevit, Morton Schubert, Jonathan Weller, Sarah Brüningk, Elisabeth Rushing, Johannes Sarnthein, Dorothee Gramatzki, Levin Häni, Andreas Raabe, Anna M. Zeitlberger, Oliver Bozinov, Emilie Le Rhun, Michael Weller, Luca Regli, Marian C. Neidert   +19 more
wiley   +1 more source

Predicting the Future Burden of Renal Replacement Therapy in Türkiye Using National Registry Data and Comparative Modeling Approaches

Therapeutic Apheresis and Dialysis, Volume 30, Issue 2, Page 254-260, April 2026.
ABSTRACT Background Chronic kidney disease is a growing public health problem worldwide, and the number of patients requiring renal replacement therapy is steadily increasing. Türkiye has experienced a similar rise in both the incidence and prevalence of renal replacement therapy over the past decades; however, national‐level projections of future ...
Arzu Akgül, Neriman Sıla Koç, Berrak Itır Aylı   +2 more
wiley   +1 more source

Recurrent Glioblastoma and the Tumor Immune Landscape: Emerging Immunotherapeutic Strategies. [PDF]

Immunotargets Ther
Cao Z, Tong S, Wang Z, Ji C, Zhang C, Dai X, Wu B.   +6 more
europepmc   +1 more source

Tirbanibulin 1% real‐world use in 679 actinic keratoses patients during warm season (SUMM‐AK study)

Journal of the European Academy of Dermatology and Venereology, EarlyView.
A. Carugno, G. Nazzaro, L. Argnani, F. Bellinato, E. Zappia, M. V. Masala, G. Dal Bello, M. Valenti, G. Addari, G. Ciccarese, M. Bruni, E. Trovato, G. Paolino, R. Balestri, A. D'Arino, C. Magnoni, E. Zavattaro, G. Toni, R. Giuffrida, A. Verdelli, S. Caccavale, A. Villani, S. Giacalone, S. Recalcati, S. Barruscotti, S. Bighetti, L. Bettolini, G. Fiorillo, L. Germi, S. Fazio, S. D. Infusino, L. Eibenschutz, A. Cesari, M. Dragotto, G. B. M. Zolo, P. Savoia, I. Zalaudek, E. Sala, E. Errichetti, S. R. Mercuri, M. Esposito, C. Foti, L. Atzori, M. Ardigò, P. Danese, S. Ribero, P. Gisondi, A. V. Marzano, N. Zerbinati   +48 more
wiley   +1 more source

Histone H4K8 lactylation promotes glioblastoma progression by inducing NUPR1-mediated autophagosome‒lysosome fusion. [PDF]

Theranostics
Zhao J, Liu X, He Y, Sun Q, Xue Z, Tang Z, Liu J, Wang J, Li C, Wang X, Yang N, Qiu C.   +11 more
europepmc   +1 more source

ATP release mediated by TRPM3 enhances invasion in glioblastoma. [PDF]

Anim Cells Syst (Seoul)
Bae KG, Song CW, Yoo JH, Lee M, Koo N, Lee G, Park YM, Yoo J, Hwang IY, Woo DH, Lee CJ, Han KS.   +11 more
europepmc   +1 more source

The Application of PD-1 Inhibitors in Immunotherapy for Glioblastoma. [PDF]

FASEB J
Dong MZ, Cui M, Qu LZ, Che HY, Guan HJ.
europepmc   +1 more source